AdAlta Limited (ASX:1AD)
Australia · Delayed Price · Currency is AUD 0.0030
-0.0005 (-14.29%)
Oct 9, 2026, 11:38 AM AEST
AdAlta Market Cap
AdAlta has a market cap or net worth of 9.64 million as of October 9, 2026. It is the 43,729th most valuable company in the world and the 1,362nd biggest in Australia. Its market cap has increased by 213.51% in one year.
Market Cap
9.64M
Enterprise Value
8.35M
Revenue
404.25K
Global Rank
Country Rank
#1,362 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since August 22, 2016, AdAlta's market cap has decreased from 28.00M to 9.64M, a decrease of -65.58%. That is a compound annual growth rate of -9.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 11.24M | 63.27% |
| Dec 31, 2025 | 6.89M | -31.84% |
| Dec 30, 2024 | 10.10M | -19.94% |
| Dec 29, 2023 | 12.62M | -2.04% |
| Dec 29, 2022 | 12.88M | -45.79% |
| Dec 29, 2021 | 23.76M | -22.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Argenica Therapeutics | 16.70M |
| EZZ Life Science Holdings | 16.47M |
| Cambium Bio | 15.89M |
| ReNerve | 14.99M |
| Immuron | 14.53M |
| Invex Therapeutics | 8.27M |
| Bio-Gene Technology | 7.01M |
| Vectus Biosystems | 6.53M |